biotech News

Next May 21 - 23, 2012 IESE, Business School will offer the Short Focused Program "Challenges in the European Healthcare Market: Winning Through Innovation".

Following an extensive national search, Fitzsimons Redevelopment Authority (FRA) has named Steve VanNurden as its new President & CEO. He comes to FRA from Mayo Clinic in Rochester, MN.

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity Report

Antibody-Drug Conjugates 2011 – real breakthrough still to come: a Technology, Stakeholder and R&D Pipeline Analysis Report

These facilities are available for the production of active raw materials for industrial application by companies researching new pharmaceuticals and products

Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations

The Board of TGI approved one time special dividend in the form shares of NANOREGEN.

John D. Steinbruner’s self-published novel issues a warning call about the management of dangerous biotechnology that resonates with the current dispute over the H5N1 Avian influenza experiments.

Auxiliis-Pharma CRO aligns with Svabhegy Paediatric Hospital, the first specialized paediatric CROs (EU) focusing on paediatric clinical trials for orphan drugs and special drug development for children. The new company is called Auxiliis-Pharma PCRS

Despite China’s rapid economic growth and the influx of thousands of global companies into that country over the past two decades, it is not too late for biotech companies to enter China, reports Genetic Engineering & Biotechnology News (GEN).

Bharatbook added a new report on " US Biotech Market Analysis " which gives an overview, Demand, Supply Trends and industry analysis reports.

Greiner Bio-One is announcing the 2nd phase in their expansion plan in Monroe, NC has been started.

M.D. Mallya , Gopinath , Sushil Karwa , Ajit Joshi , Dr Kannan Vishwanathan , Vijay Kalantri , Paritosh Joshi , Shailendra Singh , Dr BR Jagashetty,,François Licoppe ,Naveen Surya & Ashish Agarwal are among those to address at Conclave 2012

Seamlessly Integrated R&D, Production, Sales and Marketing Processes to Ensure Success in this High Growth Market

New pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR.

EuropaBio and IntetechPira announce call for papers for EFIB 2012 - the European Forum for Industrial Biotechnology and the Biobased economy.

Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.

The latest generation hydrogen peroxide bio-decontamination technology from Bioquell has now achieved Australian C-Tick approval. Targeted at the life sciences and healthcare markets, this unique methodology is used to eradicate microbes.

Through attending the annual meeting, CMCI has given excellent impressions on cow-breeding companies, and is expected to seek for further development opportunities.

Industry wide economic climate study reveals bleak outlook for Pharmaceutical Industry in new report from Pharma-IQ.com

U.S. Army’s Presidio of Monterey DFMWR Incorporates Proactive Solution to Bacteria …Long-lasting antimicrobial technology will fight bacteria growth 24/7 for up to 90 days with one application …

A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.

Technical Expertise, Potential for Time and Cost Savings Underlines Viability of Contract Outsourcing

A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.

CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.

Peptides International announces new management structure, including new President and Chief Operating officers, and Vice President, following very successful year and expanded opportunities, especially in custom peptide synthesis.

Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference

The funds will enable the Company to continue the development of TCD-717, its leading product currently in a Phase I clinical trial for the treatment of cancer, as well as expanding its pipeline.

LifeSensors, Inc. announced today that they have appointed Dr. Mark Engleka to the position of Sales and Marketing Director.

Kim Holt, Scientific manager for Chemistry at South West Water, joins IQPC Exchange to discuss the key learnings and tools from her experience at South West Water to achieve key business objectives through smarter and more efficient data management

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning).

CHI’s Event Short Course is being held at the Molecular Med TRI-CON 2012 on February 20th at The Moscone North Convention Center in San Francisco.

This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

This release of Proteome Cluster adds support for search parameter imports, sequence-based refinement for X!, Common file types and fixes IE-related bugs.

Top Healthcare, Biotech and Pharmaceutical Leaders to Meet with Investors in Search of Breakthrough Healthcare Solutions at 'The Global Leaders Healthcare Forum' on January 10

IQPC’s 13th Lean Six Sigma for Pharmaceutical, Biotech, and Medical Device Excellence conference gathers industry leaders and features over 28 in-depth case studies and four workshops addressing top industry concerns

Werner Kexel, Managing Director, Eurocat and BSI, joins IQPC to discuss the 3rd revision to the standards guideline 60601 and tips for medical device manufacturers on how to prepare for the changes.

Kim Holt, Scientific manager for Chemistry at South West Water, joins IQPC Exchange to discuss the key learnings and tools from her experience at South West Water to achieve key business objectives

In the last few years there has been a huge leap in the amount of intuitive and interactive technology available to individuals and organisations in order to make their lives easier. Increasingly, laboratories are leaving paper-based data management

As technology advances, software design plays an increasingly critical role in a growing number of healthcare divisions. In the global medical device industry, little has had the same level of impact on the design of software for medical devices

Enormous technological leaps have changed almost every aspect of the modern lives we lead and how our jobs are done.

PCT Law Group announces the addition of Patrick Delaney to its Northern Virginia office. Mr. Delaney is an accomplished attorney with over 12 years of experience in patent law representing Fortune® 100 corporations and small to large companies.

SAN FRANCISCO, Nov. 30, 2011 – Myrtle Potter, one of America’s foremost healthcare leaders, will speak to a unique gathering of investors and CEOs in healthcare, biotech and pharma at The Global Leaders Healthcare Forum on Tuesday, Jan. 10, 2012.

New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

Binder Biomedical, DemeRx, Miami-Dade Chamber of Commerce and Specialty Telehealth Services are moving to the Miami Health District; UMLSTP’s occupancy now at 63%

Ananda Mohan Chakrabarty and Meir Pugatch Perez join the advisory board of the Journal of Commercial Biotechnology.

The Institute of Life Sciences (ILS) has partnered with the Federation of Asian Biotech Associations (FABA) to scrutinize and recognize innovations through the BioAsia Innovation award and BioAsia Young Minds Award 2012.

The BBC’s Jeremy Paxman to moderate interactive discussion on realities and myths of ongoing biofuels debate

Healthcare is in crisis throughout the world, but an innovative forum will seek solutions by connecting health, biotech and pharmaceutical CEOs and other senior executives with institutional investors and business development executives.